Page 6 - Dan Lyons News Today : Breaking News, Live Updates & Top Stories | Vimarsana

We asked a bunch of founders, business leaders and entrepreneurs to share the books they will be reading these holidays.

(Reuters) -Sanofi's CEO is under pressure to tell investors how much more he will spend on research and development (R&D) and what the likely pay-offs will be, as he seeks to boost a pipeline of future drugs and restore shareholder trust. Shares in the 108 billion euro ($117 billion) French pharmaceutical giant tumbled 15% on Oct. 27 when CEO Paul Hudson unexpectedly abandoned 2025 margin targets in order to boost the budget for testing new immunology and inflammation drugs. The market's shock reaction, compounded by a lack of details of the spending push, overshadowed Sanofi...

In this article, we discuss 12 best healthcare dividend stocks to buy now.

Imperial Oil Limited (AMEX:IMO) Q3 2023 Earnings Call Transcript October 27, 2023 Operator: Good day, and welcome to the Imperial Oil 3Q ’23 Earnings Call. Today’s conference is being recorded. At this time, I would like to turn the conference over to Mr. Dave Hughes, Vice President of Investor Relations. Please go ahead. Dave Hughes: […]

Operator: Good day, and welcome to the Imperial Oil 3Q '23 Earnings Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr.